The antimicrobial action of low-molar-mass chitosan, chitosan derivatives and chitooligosaccharides on bifidobacteria
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antibakteriální látky farmakologie MeSH
- Bifidobacterium účinky léků růst a vývoj MeSH
- chitosan farmakologie MeSH
- mikrobiální testy citlivosti MeSH
- oligosacharidy farmakologie MeSH
- počet mikrobiálních kolonií MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antibakteriální látky MeSH
- chitosan succinate MeSH Prohlížeč
- chitosan MeSH
- oligosacharidy MeSH
The crude fractions of chitooligosaccharides (COS) and low-molar-mass chitosans (LMWC) were prepared by enzyme hydrolysis of chitosan (CS). Specific growth rate of B. adolescentis, B. bifidum, B. breve, B. catenulatum, B. infantis and B. longum ssp. longum was determined in the presence of 0.025 and 0.5 % COS (<5 kDa), LMWC (5-10 kDa), and 0.025, 0.1 and 0.5% of CS, chitosan succinate and chitosan glutamate in vitro. Minimum inhibitory concentrations (MIC; assayed by colony counting on TPY agar plates) of COS-LMWC and CS ranged from 0.025% to 0.75% of CS-LMWC. The growth of all bifidobacterial strains in the presence of chitosan, its derivatives and LMWC decreased at a concentration of 0.025%; the bacterial growth was completely inhibited at a concentration of 0.5%. COS did not show any inhibitory effect, an increased growth rate was even observed in the case of B. bifidum, B. catenulatum and B. infantis.
Zobrazit více v PubMed
Anaerobe. 2002 Dec;8(6):319-24 PubMed
Int J Food Microbiol. 2008 May 10;124(1):13-20 PubMed
Folia Microbiol (Praha). 2006;51(4):306-8 PubMed
Dig Dis Sci. 2007 Feb;52(2):385-9 PubMed
Antonie Van Leeuwenhoek. 2004 Oct;86(3):205-23 PubMed
Folia Microbiol (Praha). 2008;53(3):249-54 PubMed
FEMS Microbiol Ecol. 2005 Apr 1;52(2):145-52 PubMed
J Appl Microbiol. 2008 Feb;104(2):305-44 PubMed
Asia Pac J Clin Nutr. 2007;16 Suppl 1:174-7 PubMed